From PE Boardroom to Operator — What Investors Get Wrong | HCIM | Ali Evans | EP 122

Most PE investors see a 25-year-old automation business in 2026 and calculate the half-life. Ali Evans saw the one thing AI can't replicate overnight: trust earned over decades of client relationships. The conventional move would have been to exit before disruption. He acquired the company instead and stepped into the CEO chair. Ali Evans spent years at Francisco Partners and Riverside writing checks and sitting on boards before leaving the investor seat to acquire HCIM, a healthcare automation company founded in 2000. He's now CEO of the firm he owns at the fund level, navigating the rare dual role of PE investor and operating executive. The first challenge Ali walked into wasn't technical — it was linguistic. Founders and investors use the same vocabulary but optimize for completely different outcomes. Founders want to solve more customer problems. Investors want to maximize return per unit of risk. That gap destroys trust in almost every PE-backed deal, and Ali found himself on both sides of it simultaneously. The moment he became CEO, he had to stop speaking in investor math and start speaking in the language his team actually cared about: impact, autonomy, and customer outcomes. The conversation also covers why Ali doubled down on healthcare automation in the age of AI, why he thinks relationships and trust are harder to replicate than technical expertise, and the story behind Metamora — his firm's name, which comes from the hardest week of his life at a small-town football camp that taught him what it means to bond a team through crucible moments. Roland sees this founder-investor language barrier break down trust in almost every SaaS deal he advises on at the $5M–$20M stage. The misalignment isn't usually strategic — it's definitional. Both sides think they're talking about growth, but the founder means "how many more customers can we help" and the investor means "what's our IRR on this capital deployed." Ali's experience living in both seats at once confirms what Roland keeps telling both founders and their backers: you're not disagreeing on the plan. You're disagreeing on whose calculus gets to define success.

Key Moments:

01:58 — Why AI can mimic expertise but can't replace 25 years of earned trust — and why that's the bet Ali made 05:33 — The Spanish vs Portuguese problem: how founders and investors use the same words but mean completely different things 08:01 — The exact moment Ali realized his team didn't care about risk-adjusted returns — and why he had to unlearn investor-speak to lead 12:45 — Why most founder-investor conflicts aren't strategic disagreements — they're fights over whose definition of success matters 16:30 — How Ali transitioned from writing checks to running the company — and the due diligence he did on himself before becoming CEO 21:10 — What agentic AI workflows are actually doing in healthcare automation — beyond the marketing buzz 25:22 — The Metamora origin story: how a brutal high school football camp became the name of Ali's firm — and what it taught him about bonding teams through hard things HCIM is offering listeners a free workflow automation readiness assessment report. If you're running a healthcare payer operation and wondering where RPA could save real operational time, reach out at https://hcim.com/contact/ If bridging the gap between founder-speak and investor-speak is something you're navigating at the $5M–$20M stage, Midstage works directly with SaaS CEOs to translate strategy into execution without losing either side. mdstg.ac/drag-erase #PrivateEquity #HealthcareAutomation #FounderInvestorDynamics #OperatorCEO #ScalingWithoutBreaking